Clinical Trials Insight: 700016056
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 08 Jan 2008
At a glance
- Drugs Resveratrol (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Sirtris
- 08 Jan 2008 Status change from initiated to in progress, from a Sirtis media release.
- 08 Jan 2008 Interim results were reported by Sirtris Pharmaceuticals in a media release.
- 07 Jan 2008 Interim results were presented at the JPMorgan Healthcare Conference 2008.